Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...

OAKM has had a racy start as it has outsmarted IVV and a few value-heavy peers. Read why conservative Hold rating fits OAKM ...

Q4 2024 Results Conference Call February 13, 2025 8:00 AM ETCompany ParticipantsLouis Schmid - Head of Investor ...

Operator Greetings and welcome to Cognex fourth quarter and full year 2024 earnings conference call. At this time, all participants are on a listen-only mode. A question-and-answer session will follow ...

Reported EPS is $0.3068 EPS, expectations were $0.35. Operator: Good day and thank you for standing by. Welcome to the PAA ...

Portfolio Receipts of $742 million in Q4 2024 and $2,801 million for FY 2024Royalty Receipts growth of 12% in Q4 2024 and 13% for FY 2024 Net ...

Stephanie Lee Griffin; Chief Operating Officer; Roivant Sciences Ltd. Matt Gline; Chief Executive Officer, Director; Roivant Sciences Ltd. Dave Risinger; Analyst; Le ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.DozQrLpG.js ...

Detailed price information for Journey Energy Inc (JOY-T) from The Globe and Mail including charting and trades.

Welcome to the fiscal 2025 second quarter earnings call for Applied Industrial Technologies. My name is Liz and I'll be your operator for today's call. (Operator Instructions). Please note this ...

This study identifies 47,350 enhancers active in human neurons during differentiation and links some to genes involved in ...

San Francisco's federal court is home to some of the country's most ambitious lawsuits, including suits against Big Oil for the costs of climate change, and Meta for the consequences of teen ...